{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-212516","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.496287+00:00","generated_at":"2026-06-24T04:30:43.841080+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Definitive Healthcare Q2 revenue $54.5M (+37% YoY); net loss narrows; raises FY guidance","bullets":["Revenue $54.5M (+37% YoY); net loss ($9.6M) improved from ($15.0M) in Q2 2021.","Adjusted Net Income $8.9M (vs $2.0M); Adjusted EBITDA $16.3M (30% of revenue).","Enterprise customers (ARR >$100k) reached 486; launched Passport Express and Monocl ExpertInsight 2.0.","Q3 2022 revenue guidance $56-57M; FY 2022 revenue guidance $220.5-224.5M (34% YoY growth midpoint).","Unlevered free cash flow $19.1M in Q2; trailing twelve months $63.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-212516","json":"https://secwatch.observer/filing/0001193125-22-212516.json","markdown":"https://secwatch.observer/filing/0001193125-22-212516.md","text":"https://secwatch.observer/filing/0001193125-22-212516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522212516/0001193125-22-212516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312522212516/d386811d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:30:43.841080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}